Delivery Order SPE2DB22D9316-SPE2DB24FYM60

Award Date 11/9/23
Potential Completion Date 12/4/23
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $24,831 under an indefinite delivery contract with the Defense Logistics Agency to supply the pharmaceutical item PERJETA 420 MG/14 ML VIAL 14ML. As a leading pharmaceutical wholesaler, DMS Pharmaceutical Group provides brand and generic prescription drugs and over-the-counter medical supplies to support military treatment facilities worldwide. Under its indefinite delivery contract with up to $5 million in...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-three thousand one hundred eight dollars by the Defense Logistics Agency. This order is placed against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical supplies to military treatment facilities supported by the Defense Logistics Agency. The delivery order provides for fourteen milliliter vials of the oncology drug Perjeta to be delivered...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide one lot of Perjeta 420 mg/14 ml vials for $73,757.76. The delivery order has a completion date of December 7, 2023 and was awarded on November 15, 2023. DMS Pharmaceutical Group will supply the pharmaceutical item to DLA Troop Support Medical facilities from its location in Park Ridge, Illinois. DMS Pharmaceutical Group holds...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $4,138.50 under an indefinite delivery contract with the Defense Logistics Agency. The delivery order is for the supply of 14 vials of the pharmaceutical item Perjeta 420 mg/14 ml vial to fulfill requirements at Defense Logistics Agency Troop Support Medical facilities. DMS Pharmaceutical Group will provide this product from its facility located in Park Ridge, Illinois, with performance to be completed by...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency for $8,277 to supply 14 vials of Perjeta 420 mg/14 ml. The contract was awarded on November 1, 2023 and has a completion date of November 24, 2023. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency, valued at up to $5 million, to provide pharmaceuticals and medical supplies through December 2025....
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-three thousand one hundred eight dollars by the Defense Logistics Agency. This order is placed against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical supplies to support military treatment facilities globally. Under this particular order, DMS Pharmaceutical Group will provide fourteen milliliter vials of Perjeta, a breast cancer...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-four thousand eight hundred thirty-one dollars by the Defense Logistics Agency Troop Support Medical. This order is placed against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to military treatment facilities supported by the Defense Logistics Agency. Under this delivery order, DMS Pharmaceutical Group will provide...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $8,277 to supply Defense Logistics Agency Troop Support Medical with 14 vials of Perjeta 420 mg/14 ml. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to provide various pharmaceutical items and medical supplies. As a woman-owned small business and...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at four thousand one hundred thirty-eight dollars and fifty cents ($4,138.50) by the Defense Logistics Agency to provide fourteen milliliters of Perjeta 420 mg/14 ml vials. This delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to five million dollars...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-four thousand eight hundred thirty-one dollars by the Defense Logistics Agency under an existing indefinite delivery contract. The delivery order is for the supply of fourteen milliliter vials of Perjeta 420 mg to Defense Logistics Agency Troop Support Medical facilities. As a woman-owned small business, DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract through December 2025...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB24FYM60
    Delivery Order

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $12,415.50 under an indefinite delivery contract with the Defense Logistics Agency to supply pharmaceutical items. The order calls for the delivery of 4562816512 PERJETA 420 MG/14 ML VIAL 14ML to be completed by December 4, 2023. DMS Pharmaceutical Group will provide the requested pharmaceutical products to the Defense Logistics Agency as the prime contractor. No set-aside designation was used for this award. DMS Pharmaceutical Group currently holds an indefinite delivery contract with the Defense Logistics Agency valued at up to $5 million to supply various medical supplies including atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, and midazolam hydrochloride through December 2025. Delivery orders against this vehicle are issued on a firm fixed price basis to support the routine needs of military treatment facilities worldwide.

Generated 2/8/24, 10:22 AM